[go: up one dir, main page]

ES518582A0 - Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona. - Google Patents

Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona.

Info

Publication number
ES518582A0
ES518582A0 ES518582A ES518582A ES518582A0 ES 518582 A0 ES518582 A0 ES 518582A0 ES 518582 A ES518582 A ES 518582A ES 518582 A ES518582 A ES 518582A ES 518582 A0 ES518582 A0 ES 518582A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
pharmaceutical composition
composition containing
aqueous pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES518582A
Other languages
English (en)
Other versions
ES8402503A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES8402503A1 publication Critical patent/ES8402503A1/es
Publication of ES518582A0 publication Critical patent/ES518582A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
ES518582A 1981-12-28 1982-12-27 Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona. Granted ES518582A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56209972A JPS58113127A (ja) 1981-12-28 1981-12-28 ユビデカレノン含有水性液

Publications (2)

Publication Number Publication Date
ES8402503A1 ES8402503A1 (es) 1984-02-01
ES518582A0 true ES518582A0 (es) 1984-02-01

Family

ID=16581723

Family Applications (1)

Application Number Title Priority Date Filing Date
ES518582A Granted ES518582A0 (es) 1981-12-28 1982-12-27 Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona.

Country Status (9)

Country Link
US (1) US4483873A (es)
EP (1) EP0083108B1 (es)
JP (1) JPS58113127A (es)
KR (1) KR880002410B1 (es)
AT (1) ATE22006T1 (es)
CA (1) CA1176568A (es)
DE (1) DE3273257D1 (es)
ES (1) ES518582A0 (es)
NO (1) NO156553C (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
JPS5910511A (ja) * 1982-07-07 1984-01-20 Eisai Co Ltd 脂溶性物質含有水性液
JPS6025918A (ja) * 1983-07-25 1985-02-08 Ajinomoto Co Inc 脂溶性薬物含有水性液
CH661438A5 (it) * 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
US4824669A (en) * 1985-04-11 1989-04-25 Board Of Regents, The University Of Texas System Formulations of coenzyme Q10 for intravenous use
DE3524788A1 (de) * 1985-07-11 1987-01-22 Lentia Gmbh Stabile, intravenoes applizierbare, waessrige fettemulsion und ein verfahren zu deren herstellung
CH667387A5 (it) * 1985-12-24 1988-10-14 Seuref Ag Formulazioni farmaceutiche acquose di ubichinone.
US4911929A (en) * 1986-08-29 1990-03-27 The United States Of America As Represented By The Secretary Of The Navy Blood substitute comprising liposome-encapsulated hemoglobin
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
IT1250672B (it) * 1991-07-11 1995-04-21 Idb Holding Spa Formulazioni orali di ubidecarenone in soluzione acquosa
ES2051643B1 (es) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
GR1001364B (el) * 1992-10-16 1993-10-29 Inverni Della Beffa Farma Από του στόματος συν?έσεις ουβιδεκαρενόνης υπό μορφήν υδατικών διαλυμάτων.
JP3106820B2 (ja) * 1993-12-08 2000-11-06 アールティーエー・アソシエーツ有限会社 畜肉、魚肉およびこれらの加工品の鮮度保持剤並びに生産性改善剤
DE4405545A1 (de) * 1994-02-22 1995-08-31 Dietl Hans Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation
US6403116B1 (en) 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
EP2371363B1 (en) 2004-01-22 2020-04-08 University of Miami Coenzyme Q10 formulations for use in the treatment of solid tumours
US7803366B2 (en) * 2004-05-07 2010-09-28 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
KR20100136997A (ko) 2008-04-11 2010-12-29 싸이토테크 랩스, 엘엘씨 암세포에서 아폽토시스를 유도하는 방법 및 용도
JPWO2010021034A1 (ja) * 2008-08-20 2012-01-26 昭和電工株式会社 皮膚外用剤
WO2010111397A1 (en) * 2009-03-24 2010-09-30 Adds Pharmaceuticals Llc Stabilized solubility-enhanced formulations for oral delivery
SG10201402287TA (en) 2009-05-11 2014-07-30 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
WO2012138765A1 (en) 2011-04-04 2012-10-11 Berg Pharma Llc Methods of treating central nervous system tumors
MX380565B (es) 2013-04-08 2025-03-12 Berg Llc Terapias combinadas de coenzima q10 para el tratamiento de cáncer.
AU2014315186B2 (en) 2013-09-04 2020-02-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme Q10
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
PL3476388T3 (pl) 2017-10-24 2022-01-24 Difass International S.P.A. Kompozycja zawierająca koenzym q10 i piperynę
EP4101442B1 (en) * 2021-06-11 2025-09-03 Tradichem Industrial Services, S.L. Process for preparing compacted coenzyme q10 particles of high density and improved flowability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5845403B2 (ja) * 1976-02-14 1983-10-08 エーザイ株式会社 補酵素qを主成分とする膵機能亢進剤
JPS5356315A (en) * 1976-11-01 1978-05-22 Eisai Co Ltd Emulsified solution of fat soluble drugs
JPS5562010A (en) * 1978-10-31 1980-05-10 Ajinomoto Co Inc Fat emulsion for intravenous injection
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
FR2471384A1 (fr) * 1979-12-11 1981-06-19 Richter Gedeon Vegyeszet Procede de preparation de tartrate d'ergotamine
FR2472384A1 (fr) * 1979-12-27 1981-07-03 Sederma Sa Utilisation en cosmetologie de complexes naturels constitues d'ubiquinones et de phospholipides

Also Published As

Publication number Publication date
ES8402503A1 (es) 1984-02-01
EP0083108B1 (en) 1986-09-10
NO156553C (no) 1987-10-14
NO156553B (no) 1987-07-06
ATE22006T1 (de) 1986-09-15
US4483873A (en) 1984-11-20
CA1176568A (en) 1984-10-23
JPS58113127A (ja) 1983-07-05
KR840002650A (ko) 1984-07-16
EP0083108A3 (en) 1983-12-14
NO824380L (no) 1983-06-29
JPH0322363B2 (es) 1991-03-26
KR880002410B1 (ko) 1988-11-08
DE3273257D1 (en) 1986-10-16
EP0083108A2 (en) 1983-07-06

Similar Documents

Publication Publication Date Title
ES518582A0 (es) Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona.
ES500916A0 (es) Un procedimiento para la preparacion y estabilizacion de una composicion blanqueante acuosa que contiene peroxido de hi-drogeno.
ES8600306A1 (es) Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos.
MX7536E (es) Procedimiento para preparar caramelo macizo que contiene sorbitol
ES515443A0 (es) Procedimiento para la preparacion de productos para la proteccion contra la polilla.
MX9304793A (es) Glicanas de actividad inmunoestimulante.
ES517296A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
IE822519L (en) Phosphonic acid derivatives
IT8224053A0 (it) Procedimento per la preparazione di derivati di eburnamonina.
ES503171A0 (es) Un procedimiento para la preparacion de una composicion detergente liquida acuosa.
ES523878A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
MX3897E (es) Un procedimiento para la preparacion de composiciones insecticidas que contienen (6,7,8,9,10,10-hexacloro-1,5,5a,6,9,9a,-hexahidro-6,9-metano-2,4,3,-benzodioxatiepin-3-oxido)
ES507277A0 (es) Procedimiento para preparar derivados de sulfonilurea de efecto antidoto contra herbicidas del tipo tiolcarbamato.
ES498016A0 (es) Procedimiento para la produccion de compuestos que contienen clorotriacinilo.
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
IT1210473B (it) Procedimento per la preparazione di derivati ergolinici.
IT8023404A0 (it) Procedimento per la preparazione di derivati del15-idrossiimmino-e-omoeburnano.
IT8002918A0 (it) Procedimento per la stabilizzazione di vitamine.
ES520782A0 (es) Procedimiento para hacer emetica una composicion herbicida acuosa.
IT8026229A0 (it) Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnani ci.
ES522904A0 (es) Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.
MX9202984A (es) Composiciones farmaceuticas que contienen salbutamol.
ES518341A0 (es) Procedimiento para la preparacion del 7-metilo-3-metileno-7-octeno-1-ilo-propionato.
JPS5430185A (en) Mandelic acid derivative and carcinostatic agnet containing the same

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010402